Roderick Wong - 18 Jun 2026 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: RCKT
Reported as of: 18 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jul 2026, 20:00:01 UTC
Prior SEC filing: 18 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Martin Wilson, as attorney-in-fact for Roderick Wong

Key filing fact

Roderick Wong filed Form 4 for ROCKET PHARMACEUTICALS, INC. (RCKT) on 06 Jul 2026.

Key facts

This page summarizes Roderick Wong's Form 4 filing for ROCKET PHARMACEUTICALS, INC. (RCKT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Jul 2026, 20:00.

Change

Previous filing in this sequence was filed on 18 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001493280 Primary reporting owner

WONG RODERICK

Relationship: Director, 10%+ Owner
Address: C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY
Signature: /s/ Martin Wilson, as attorney-in-fact for Roderick Wong
Signature date: 06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RCKT transaction

Common Stock

Award

Transaction value
Shares: +27,832
Change %: +58%
Price: $0.000000^*
Shares after: 75,499
Date: 18 Jun 2026
Ownership: Direct
Footnotes: F1

RCKT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 18,188,457
Date: 18 Jun 2026
Ownership: See footnote
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RCKT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +78,960
Change %
Price: $0.000000^*
Shares after: 78,960
Date: 18 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 78,960
Exercise price: $3.35
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027.

Footnote F2

Represents shares held by certain investment funds managed by RTW Investments, LP (the "Adviser"). The Reporting Person serves as the Managing Partner and Chief Investment Officer of the Adviser and is a director of the Issuer and Chairman of the Issuer's Board of Directors.

Footnote F3

This option represents a right to purchase a total of 78,960 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.